Ziopharm Oncology Announces First Patient Infused in CD19 RPM CAR-T Phase I Clinical Trial Being Conducted by Joint Venture Partner Eden BioCell
April 19, 2021 08:00 ET
|
ZIOPHARM Oncology Inc
BOSTON and HOUSTON and TAIPEI, Taiwan, April 19, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or the “Company”) (Nasdaq: ZIOP), announced today that in March, the first patient was...
Ziopharm Oncology to Present Poster at American Association for Cancer Research Virtual 2021 Annual Meeting
April 07, 2021 09:00 ET
|
ZIOPHARM Oncology Inc
BOSTON and HOUSTON, April 07, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or the “Company”) (Nasdaq: ZIOP), announced today it will be presenting a poster at the upcoming American...
Ziopharm Oncology Provides Leadership and Corporate Updates; Reports Fourth Quarter and Full Year 2020 Financial Results
February 25, 2021 16:05 ET
|
ZIOPHARM Oncology Inc
Heidi Hagen Appointed Interim Chief Executive Officer Replacing Dr. Laurence Cooper; Search for Permanent CEO Initiated Dr. Laurence Cooper Expected to Continue with Company in a Scientific Advisory...
Ziopharm Oncology to Report Fourth Quarter and Full Year 2020 Financial Results and Host Webcast on February 25, 2021
February 16, 2021 16:01 ET
|
ZIOPHARM Oncology Inc
BOSTON, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (the “Company”) (Nasdaq: ZIOP), today announced the Company will host a conference call and webcast to discuss financial results for...
Ziopharm Oncology Announces Election of Robert Postma to its Board of Directors
February 05, 2021 09:00 ET
|
ZIOPHARM Oncology Inc
BOSTON, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or “the Company”) (Nasdaq:ZIOP) today announced the election of Robert Postma to its Board of Directors (the “Board”),...
Ziopharm Oncology Announces Election of James Huang as Chairman of the Board of Directors
January 14, 2021 08:00 ET
|
ZIOPHARM Oncology Inc
– Mr. Huang is a veteran industry entrepreneur with 20+ years founding and funding biotech innovation – – Heidi Hagen elected Lead Independent Director – BOSTON, Jan. 14, 2021 (GLOBE NEWSWIRE) --...
Ziopharm to Participate in Upcoming January Conferences
December 23, 2020 16:01 ET
|
ZIOPHARM Oncology Inc
BOSTON, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or “the Company”) (Nasdaq: ZIOP), today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer of...
Ziopharm Oncology Announces Clearance of Taiwan’s First IND of Non-viral CAR-T for the Treatment of Relapsed CD19+ Leukemias and Lymphomas
December 21, 2020 16:01 ET
|
ZIOPHARM Oncology Inc
– Advances Eden BioCell’s clinical program to validate Rapid Personalized Manufacturing (RPM) – – Clinical trial to study autologous CD19-specific CAR-T using RPM technology designed to reduce cost...
Ziopharm Comments on Consent Solicitation Results
December 16, 2020 16:01 ET
|
ZIOPHARM Oncology Inc
BOSTON, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP) (“Ziopharm” or the “Company”), today issued a statement in connection with the consent solicitation (the “Consent...
Ziopharm Oncology Announces Chief Financial Officer to Step Down
December 14, 2020 16:02 ET
|
ZIOPHARM Oncology Inc
BOSTON, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP) (“Ziopharm” or the “Company”), today announced that Satyavrat “Sath” Shukla, CFA, Chief Financial Officer, has...